These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 12759801

  • 41. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

  • 42. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Morgan MJ.
    Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
    [Abstract] [Full Text] [Related]

  • 43. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [Abstract] [Full Text] [Related]

  • 44. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [Abstract] [Full Text] [Related]

  • 45. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 46. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P, Curran HV, Grasby P.
    Br J Psychiatry; 2009 Apr 01; 194(4):355-9. PubMed ID: 19336788
    [Abstract] [Full Text] [Related]

  • 47. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB, Kühn KU, Hoenig K, Maier W, Wagner M.
    Neuropsychopharmacology; 2004 May 01; 29(5):982-90. PubMed ID: 14970829
    [Abstract] [Full Text] [Related]

  • 48. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
    Hoshi R, Pratt H, Mehta S, Bond AJ, Curran HV.
    J Psychopharmacol; 2006 Mar 01; 20(2):291-301. PubMed ID: 16510487
    [Abstract] [Full Text] [Related]

  • 49. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M, Fisk JE, Murphy P, Montgomery C.
    Hum Psychopharmacol; 2004 Jun 01; 19(4):225-34. PubMed ID: 15181650
    [Abstract] [Full Text] [Related]

  • 50. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users.
    Croft RJ, Klugman A, Baldeweg T, Gruzelier JH.
    Am J Psychiatry; 2001 Oct 01; 158(10):1687-92. PubMed ID: 11579003
    [Abstract] [Full Text] [Related]

  • 51. Decreased pain tolerance and mood in recreational users of MDMA.
    O'Regan MC, Clow A.
    Psychopharmacology (Berl); 2004 May 01; 173(3-4):446-51. PubMed ID: 14752588
    [Abstract] [Full Text] [Related]

  • 52. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.
    Price LH, Ricaurte GA, Krystal JH, Heninger GR.
    Arch Gen Psychiatry; 1989 Jan 01; 46(1):20-2. PubMed ID: 2562914
    [Abstract] [Full Text] [Related]

  • 53. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence.
    Dafters RI, Duffy F, O'Donnell PJ, Bouquet C.
    Psychopharmacology (Berl); 1999 Jul 01; 145(1):82-90. PubMed ID: 10445376
    [Abstract] [Full Text] [Related]

  • 54. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W.
    Lancet; 2001 Dec 01; 358(9296):1864-9. PubMed ID: 11741626
    [Abstract] [Full Text] [Related]

  • 55. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W.
    Psychol Med; 2008 Sep 01; 38(9):1309-17. PubMed ID: 17988417
    [Abstract] [Full Text] [Related]

  • 56. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK, Campbell Z, Jovanovski D.
    Hum Psychopharmacol; 2007 Oct 01; 22(7):427-35. PubMed ID: 17896346
    [Abstract] [Full Text] [Related]

  • 57. Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
    Verheyden SL, Hadfield J, Calin T, Curran HV.
    Psychopharmacology (Berl); 2002 Apr 01; 161(1):23-31. PubMed ID: 11967627
    [Abstract] [Full Text] [Related]

  • 58. Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Groth-Marnat G, Howchar H, Marsh A.
    Percept Mot Skills; 2007 Feb 01; 104(1):43-55. PubMed ID: 17450963
    [Abstract] [Full Text] [Related]

  • 59. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C, Forcella M, Beretta G, Grieco A, Campana G.
    Addict Biol; 2005 Jun 01; 10(2):187-95. PubMed ID: 16191672
    [Abstract] [Full Text] [Related]

  • 60. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
    Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ.
    Biol Psychiatry; 2001 Oct 01; 50(7):550-4. PubMed ID: 11600108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.